Table 5 Intraoperative and postoperative characteristics
Variable | Result |
|---|---|
Mitral valve | Â |
Repaired | 1.9% (N = 4) |
Mechanical | 59.7% (N = 126) |
Bioprosthetic | 38.4% (N = 81) |
Tricuspid valve | Â |
Native | 61.1% (N = 129) |
Repaired | 19.9% (N = 42) |
Mechanical | 6.2% (N = 13) |
Bioprosthetic | 12.8% (N = 27) |
Aortic valve | Â |
Native | 75.8% (N = 160) |
Repaired | 0.5% (N = 1) |
Mechanical | 15.6% (N = 33) |
Bioprosthetic | 8% (N = 17) |
Pulmonary valve | Â |
Native | 75.4% (N = 159) |
Repaired | 0.5% (N = 1) |
Mechanical | 17.5% (N = 37) |
Bioprosthetic | 6.6% (N = 14) |
Bentall procedure | 5.2% (N = 11) |
Time to last redo (years) | 14.2 ± 9.2 (Range 0.2–53) |
RBC (units) | 4.2 ± 3.4 (Range 0–30) |
Platelets (units) | 6.3 ± 4.8 (Range 0–30) |
FFP (units) | 4 ± 5.1 (Range 0–60) |
Cardiopulmonary bypass time (min) | 150.2 ± 75.9 (Range 39–460), N = 151 |
Aortic cross clamp time (min) | 105.1 ± 56.8 (Range 27–285), N = 152 |
Intraoperative IABP | 2.8% (N = 6) |
Postoperative IABP | 2.4% (N = 5) |
Intraoperatively ECMO | 2.8% (N = 6) |
Duration (days) | 6.5 ± 7.9 (Range 1–22) |
Postoperatively ECMO | 3.3% (N = 7) |
Duration (days) | 5.3 ± 3.8 (Range 1–10) |
Circulatory arrest time (mins) | 36.7 ± 8.5 (Range 27–43) |
Perioperative MI | 1% (N = 2) |
ICU LOS (days) | 10 ± 20.5 (Range 0-192) |
reintubation | 3.8% (N = 8) |
ICU tracheostomy | 5.7% (N = 12) |
Cardiac arrest postoperatively | 7.6% (n = 16) |
Resuscitated | 56.3% (N = 9) |
Failed resuscitation | 43.7 (N = 7) |
Stroke | 5.2% (N = 11) |
Severe bleeding | 10.4% (N = 22) |
Re-intervention for bleeding | 68.2% (N = 15) |
Infection | 18.5% (N = 39) |
Patients with multiple infections* | 5.7% (N = 12) |
UTI | 10.3% (N = 4) |
Wound infection | 25.6% (N = 10) |
Pneumonia | 59% (N = 23) |
BSI | 43.6% (N = 17) |
Arrythmia | 46% (N = 97) |
Atrial fibrillation/flutter | 17.5% (N = 17) |
Permanent pacemaker | 46.4% (N = 44) |
Other cardiac problems | 25.6% (N = 54) |
Noncardiac problems | 6.6% (N = 14) |
Pulmonary embolism | 1% (N = 2) |
Acute limb ischemia | 1% (N = 2) |
Dialysis | 5.7% (N = 12) |
Hospital LOS (days) | 21 ± 24.1 (Range 0-192) |
NYHA-I | 7% (N = 15) |
NYHA-II | 27.5% (N = 56) |
NYHA-III | 39.3% (N = 83) |
NYHA-IV | 27% (N = 57) |